<DOC>
	<DOCNO>NCT00953914</DOCNO>
	<brief_summary>The purpose study determine pyridostigmine bromide improve heart rate variability type 2 diabetes mellitus subject cardiovascular autonomic neuropathy .</brief_summary>
	<brief_title>Pyridostigmine Its Effects Autonomic Modulation Diabetic Patients</brief_title>
	<detailed_description>The reduced heart rate variability associate increase risk death patient diabetes mellitus . Cholinesterase inhibition pyridostigmine bromide increase heart rate variability normal individual congestive heart failure subject effect patient diabetes mellitus unknown . Based evidence , test short-term administration pyridostigmine bromide increase heart rate variability patient diabetes mellitus .</detailed_description>
	<mesh_term>Diabetes Complications</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<criteria>diabetes mellitus myocardial infarction acute ischemic syndrome second third degree atrioventricular block active alcoholism thyroid dysfunction chronic obstructive pulmonary disease history intolerance pyridostigmine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>pyridostigmine</keyword>
	<keyword>autonomic modulation</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>heart rate variability</keyword>
</DOC>